{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:17:02Z","timestamp":1792099022205,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Epilepsy Research Fund"},{"name":"\u201cFundaci\u00f3n Alfonso Mart\u00edn Escudero\u201d"},{"name":"HHV6 Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.seizure.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:38:07Z","timestamp":1533559087000},"page":"16-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Pathophysiology of convulsive status epilepticus"],"prefix":"10.1016","volume":"68","author":[{"given":"Iv\u00e1n","family":"S\u00e1nchez Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard P.","family":"Goodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod C.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2018.08.002_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2018.08.002_bib0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","article-title":"Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR)","volume":"55","author":"Coeytaux","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.50.3.735","article-title":"Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984","volume":"50","author":"Hesdorffer","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047474","article-title":"Risk factors associated with death in in-hospital pediatric convulsive status epilepticus","volume":"7","author":"Loddenkemper","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.seizure.2018.08.002_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1542\/peds.83.3.323","article-title":"Low morbidity and mortality of status epilepticus in children","volume":"83","author":"Maytal","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.seizure.2018.08.002_bib0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","article-title":"Incidence and mortality of generalized convulsive status epilepticus in California","volume":"58","author":"Wu","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eplepsyres.2017.07.006","article-title":"Status epilepticus-related etiology, incidence and mortality: a meta-analysis","volume":"136","author":"Lv","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.08.002_bib0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1046\/j.1528-1157.2003.63702.x","article-title":"Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy","volume":"44","author":"Vignatelli","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2018.08.002_bib0055","first-page":"S37","article-title":"Pathophysiological mechanisms of brain damage from status epilepticus","volume":"34","author":"Wasterlain","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.1973.00490190019001","article-title":"Physiology of status epilepticus in primates","volume":"28","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0002-9343(80)90415-5","article-title":"Status epilepticus. Causes, clinical features and consequences in 98 patients","volume":"69","author":"Aminoff","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.seizure.2018.08.002_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1212\/WNL.34.2.255","article-title":"Changes in plasma catecholamines after tonic-clonic seizures","volume":"34","author":"Simon","year":"1984","journal-title":"Neurology"},{"issue":"4)Pt 1","key":"10.1016\/j.seizure.2018.08.002_bib0080","first-page":"354","article-title":"Changes in cerebral dynamics associated with seizures","volume":"11","author":"White","year":"1961","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archneur.1973.00490190028002","article-title":"Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events","volume":"28","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0035-1552618","article-title":"Hippocampal sclerosis: causes and prevention","volume":"35","author":"Walker","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF02224538","article-title":"Erkrankung des ammonshornes als aetiologisches moment der epilepsie","author":"Sommer","year":"1880","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2018.08.002_bib0100","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1528-1167.2010.02636.x","article-title":"Adverse outcomes following convulsive status epilepticus in children: relationship with hippocampal injury","volume":"51","author":"Scott","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.1973.00490260026003","article-title":"Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons","volume":"29","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2018.08.002_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2018.08.002_bib0120","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1212\/WNL.43.3_Part_1.483","article-title":"Status epilepticus at an urban public hospital in the 1980s","volume":"43","author":"Lowenstein","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","article-title":"Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study","volume":"7","author":"Chin","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.08.002_bib0140","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2018.08.002_bib0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4886(88)90010-6","article-title":"Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam","volume":"101","author":"Walton","year":"1988","journal-title":"Exp Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0150","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2018.08.002_bib0155","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2018.08.002_bib0160","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1523\/JNEUROSCI.20-21-07972.2000","article-title":"Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons","volume":"20","author":"Kittler","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2018.08.002_bib0165","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1073\/pnas.1415126112","article-title":"KCC2 activity is critical in limiting the onset and severity of status epilepticus","volume":"112","author":"Silayeva","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.seizure.2018.08.002_bib0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuropharm.2016.04.029","article-title":"Compromising KCC2 transporter activity enhances the development of continuous seizure activity","volume":"108","author":"Kelley","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.seizure.2018.08.002_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2018.08.002_bib0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2018.08.002_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12028-012-9790-1","article-title":"Treatment of status epilepticus: an international survey of experts","volume":"18","author":"Riviello","year":"2013","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2018.08.002_bib0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2018.08.002_bib0205","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","article-title":"Time from convulsive status epilepticus onset to anticonvulsant administration in children","volume":"84","author":"S\u00e1nchez Fern\u00e1ndez","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/epi.13270","article-title":"Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus","volume":"57","author":"Sivakumaran","year":"2016","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2018.08.002_bib0215","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus","volume":"75","author":"Gainza-Lein","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0220","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/epi.12136","article-title":"Early developmental outcomes in children following convulsive status epilepticus: a longitudinal study","volume":"54","author":"Martinos","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","article-title":"Outcome of paediatric convulsive status epilepticus: a systematic review","volume":"5","author":"Raspall-Chaure","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yebeh.2003.12.012","article-title":"Time to treatment in prolonged seizure episodes","volume":"5","author":"Pellock","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.08.002_bib0235","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/epi.12526","article-title":"Emergency management of febrile status epilepticus: results of the FEBSTAT study","volume":"55","author":"Seinfeld","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1212\/WNL.0000000000003550","article-title":"Refractory status epilepticus in children with and without prior epilepsy or status epilepticus","volume":"88","author":"S\u00e1nchez Fern\u00e1ndez","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2018.08.002_bib0245","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2018.08.002_bib0250","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1073\/pnas.1403285111","article-title":"Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors","volume":"111","author":"Abramian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 6","key":"10.1016\/j.seizure.2018.08.002_bib0255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/epi.13999","article-title":"Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0265","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0270","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0275","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0280","unstructured":"SAGE therapeutics. Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus. Last accessed: December, 23, 2017. http:\/\/investor.sagerx.com\/news-releases\/news-release-details\/sage-therapeutics-reports-top-line-results-phase-3-status-trial."},{"issue":"Suppl. 8","key":"10.1016\/j.seizure.2018.08.002_bib0285","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1528-1167.2011.03243.x","article-title":"Rational polytherapy in the treatment of acute seizures and status epilepticus","volume":"52","author":"Wasterlain","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2018.08.002_bib0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/WNP.0000000000000217","article-title":"Monotherapy or polytherapy for first-line treatment of SE?","volume":"33","author":"Alvarez","year":"2016","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2018.08.002_bib0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2015.02.027","article-title":"Single versus combinatorial therapies in status epilepticus: novel data from preclinical models","volume":"49","author":"L\u00f6scher","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2018.08.002_bib0300","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1474-4422(15)00296-3","article-title":"Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial","volume":"15","author":"Navarro","year":"2016","journal-title":"Lancet Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118301596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118301596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:53:30Z","timestamp":1761011610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118301596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":60,"alternative-id":["S1059131118301596"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2018.08.002","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology of convulsive status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}